Developer docs
API playgroundTry for free, no card

Search company profiles

Rare Disorders Nz

Full company profile

uuid00vpgbs

Namestring
Rare Disorders Nz
Legal namestring
Rare Disorders New Zealand
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Rare Disorders New Zealand (RDNZ), founded in 2017 (operating since at least 2017 as NZORD, rebranded 2019), is a registered New Zealand charity headquartered in Wellington that serves as the collective voice for approximately 300,000 New Zealanders living with a rare disorder and their whānau (families). The organization operates through a federation model, providing services and advocacy on behalf of more than 150 disorder-specific support groups, and delivers a portfolio that includes a support group directory, patient resource hub, parent and caregiver guides, navigation services for health and disability systems, mental health resources, and a Round Table of Companies forum established in 2019 for pharma engagement. Underlying technology is minimal — RDNZ is not a technology company but a content, community, and policy platform delivered through a website (raredisorders.org.nz), newsletters, podcasts, Facebook communities (including a Māori-specific group), and in-person events such as Rare Disorders Month.

RDNZ's strategic reach has expanded materially since 2023 through three foundational moves: delivery of New Zealand's first Rare Disorders Strategy in 2023, establishment of the Cross-Party Parliamentary Group on Rare and Undiagnosed Disorders (14 MPs) in March 2025, and recognition as the 19th ERDERA National Mirror Group — the first Southern Hemisphere non-European country — in late 2025. In late 2024, RDNZ co-launched the Rare Disorders Research Network (RDRN) with Victoria University of Wellington, growing to 50+ research members across VUW, University of Otago, and University of Auckland's Liggins Institute. A Māori Advisory Group is being established to ground the organization in Te Tiriti o Waitangi principles.

The business model is charitable rather than commercial: services are provided free of charge to patients and families, and revenue derives from donations (prominent donate button on the website), grants, fundraising events including the annual Rare Beer Challenge, and pharmaceutical industry engagement through the Round Table of Companies. RDNZ does not have investors or shareholders and is governed by a Board of Trustees chaired by Ariane Tuapola, with Chief Executive Chris Higgins also chairing the NZ ERDERA National Mirror Group. Revenue, headcount, and audited financials are not publicly disclosed, consistent with a small national charity footprint.

Short descriptiontext

Rare Disorders New Zealand (RDNZ) is a Wellington-based registered charity and the collective voice for approximately 300,000 New Zealanders living with a rare disorder, representing over 150 disorder-specific support groups through advocacy, support services, parliamentary engagement, and a national rare disorders research network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWellington, New Zealand
HQ citystring
Wellington
HQ countrystring
New Zealand
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease advocacy, patient support services, disorder support groups, health policy advocacy, rare disorders research
Industry3 codes
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYBPAGACAH
Patient Advocacy, Navigation & Access to Care
SECONDARYHLAJAJAE
Disease Registries (Cancer, Immunization, Rare Disease, etc.)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics
NAICS code3 codes
  • Individual and Family Services6241
  • Other Similar Organizations (except Business, Professional, Labor, and Political Organizations)813990
  • Human Rights Organizations813311
SIC code3 codes
  • Services-Social Services8300
  • Services-Membership Organizations8600
  • Services-Health Services8000
Product category
Rare Disease Advocacy Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Charitable Funding
TypeAffiliate Referral
Description

Rare Disorders NZ operates as a registered charity and relies on donations from the public (evidenced by prominent donate buttons on their website), grants, and potentially government funding to support their advocacy and support services for the rare disorders community.

raredisorders.org.nz
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Rare Disorders NZ is a registered charity that serves as the collective voice for the approximately 300,000 New Zealanders living with a rare disorder. The organization coordinates a network of 150+ disorder-specific support groups, delivers patient and caregiver resources, advocates for policy change through parliamentary channels, and operates the national Rare Disorders Research Network connecting researchers across institutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • First-ever Rare Disorders Strategy for New Zealand achieved through advocacy efforts
+2 more records
Product overview1 text field

Rare Disorders NZ is a national advocacy charity, not a product company. The organization serves as the collective voice for approximately 300,000 New Zealanders living with rare disorders. Its offerings consist of support services (support group directory, patient resources, mental health support, self-advocacy resources), advocacy initiatives (the Cross-Party MP Group, Māori Advisory Group, Rare Disorders Strategy), research infrastructure (Rare Disorders Research Network connecting over 50 researchers), financial support guidance (disability funding, Work and Income resources, other financial support), and information resources (genetic testing information, transition to independent living guides, parent and caregiver guide). These services work together to improve healthcare and wellbeing for people with rare health conditions through support, advocacy, and research coordination.

Product and service2 records
1Support Group Directory
CategorySupport Service
Description

A searchable directory of over 150 disorder-specific support groups connecting patients and families with rare disorders in New Zealand.

2Rare Disorders Research Network (RDRN)
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-12-01
Description

Joint collaboration establishing New Zealand's Rare Disorders Research Network. Professor Karen McBride-Henry and Dr Tara Officer received HRC Health Delivery Research Activation Grant for rare disorders research. The network is co-chaired by RDNZ Chief Executive Chris Higgins and Associate Professor Phillip Wilcox (University of Otago).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leads rare disorders research through Associate Professor Phillip Wilcox (Māori Variome project, He Kākano) and Professor Louise Bicknell (ERDERA ambassador). Multiple research leadership group members from University of Otago including Stephanie Hughes (RARITY initiative) and Louise Bicknell.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

NZ became the 19th National Mirror Group and first Southern Hemisphere non-European country recognized by ERDERA in late 2025. ERDERA has 185 organisations across 37 countries with €385 million budget. NZ NMG connects New Zealand researchers with international rare disease networks and provides potential gateway to Horizon Europe research programme.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Professor Justin O'Sullivan leads work on fast-tracking rare disease from diagnosis to custom therapies. Research on acute care genetics, trio sequencing, newborn genetic testing projects. Partnership with Māori Research Advisory Group.

5Round Table of Companies (Pharmaceutical Companies)
Strategic tierCoreTypeGTM or Marketing Partner
Description

Established 2019. Forum of pharmaceutical companies with interest in orphan drugs and therapeutic interventions for rare disorders in New Zealand. Holds two meetings annually. Provides transparent working relationships between industry and patient community while maintaining RDNZ independence. Current members include multiple pharmaceutical company logos (specific companies not named in text).

raredisorders.org.nz
6Australian National Mirror Group (via Perth Children's Hospital Rare Care Centre)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaboration through Catalyst-funded NMG/Australian partnership project. Professor Gareth Baynam leads Australian efforts. Cross-sector rare disorders research framework sharing. Plans for joint meetings and knowledge sharing on rare disease models of care.

raredisorders.org.nz
7Cross-Party Parliamentary Group on Rare and Undiagnosed Disorders (CPGRD)
Strategic tierFlagshipTypeOthers
Description

Formally established 12 March 2025 with support from Associate Minister of Health Hon. David Seymour. 14 MPs from multiple parties. National MP Hamish Campbell as Chair, Labour MP Hon. Dr. Ayesha Verrall as Deputy Chair. RDNZ provides secretariat support. Quarterly meetings.

raredisorders.org.nz
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

European umbrella for rare disease patient organisations; directly comparable as a federation of national rare disease alliances driving cross-border policy, research, and advocacy—mirroring RDNZ's role at a smaller scale within NZ and recently joining ERDERA.

TypeBroad incumbent
Description

Largest US rare disease advocacy organisation; directly comparable as a national collective voice for rare disease patients and a major policy/advocacy umbrella, with a much larger scale and portfolio including research grants and patient registries.

TypeDirect peer
Description

UK umbrella for genetic and rare condition support groups; directly comparable structure—membership-based federation of condition-specific groups providing advocacy, information, and policy influence.

4Orphanet
TypeOthers
Description

Global reference portal for rare diseases and orphan drugs providing disease classification, prevalence data, and expert resources; adjacent infrastructure that RDNZ draws upon for its 7,000-disorder framing and research evidence base.

TypeDirect peer
Description

Canada's national rare disease patient alliance; comparable as a national umbrella advocating for a national rare disease strategy, drug access reform, and research funding, with member support groups analogous to RDNZ's collective.

TypeDirect peer
Description

Australia's national rare disease advocacy body; operates the same collective-voice model serving patients across disease areas, drives national rare disease policy, and partners with RDNZ via the joint Catalyst-funded NMG initiative.

TypeRegional player
Description

UK campaign focused on rare disease policy and strategy development; comparable mission in driving national rare disease frameworks, similar to RDNZ's advocacy for NZ's first Rare Disorders Strategy.

8Malaysian Rare Disorders Society
TypeRegional player
Description

Malaysia-based rare disease patient advocacy group operating across a similarly small national population; shares the Asia-Pacific context, emerging-policy landscape, and community-collective advocacy model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rare Disorders Nz

Rare Disease Advocacy Servicesraredisorders.org.nz

Rare Disorders New Zealand (RDNZ) is a Wellington-based registered charity and the collective voice for approximately 300,000 New Zealanders living with a rare disorder, representing over 150 disorder-specific support groups through advocacy, support services, parliamentary engagement, and a national rare disorders research network.

What Rare Disorders Nz does

Rare Disorders New Zealand (RDNZ), founded in 2017 (operating since at least 2017 as NZORD, rebranded 2019), is a registered New Zealand charity headquartered in Wellington that serves as the collective voice for approximately 300,000 New Zealanders living with a rare disorder and their whānau (families). The organization operates through a federation model, providing services and advocacy on behalf of more than 150 disorder-specific support groups, and delivers a portfolio that includes a support group directory, patient resource hub, parent and caregiver guides, navigation services for health and disability systems, mental health resources, and a Round Table of Companies forum established in 2019 for pharma engagement. Underlying technology is minimal — RDNZ is not a technology company but a content, community, and policy platform delivered through a website (raredisorders.org.nz), newsletters, podcasts, Facebook communities (including a Māori-specific group), and in-person events such as Rare Disorders Month.

RDNZ's strategic reach has expanded materially since 2023 through three foundational moves: delivery of New Zealand's first Rare Disorders Strategy in 2023, establishment of the Cross-Party Parliamentary Group on Rare and Undiagnosed Disorders (14 MPs) in March 2025, and recognition as the 19th ERDERA National Mirror Group — the first Southern Hemisphere non-European country — in late 2025. In late 2024, RDNZ co-launched the Rare Disorders Research Network (RDRN) with Victoria University of Wellington, growing to 50+ research members across VUW, University of Otago, and University of Auckland's Liggins Institute. A Māori Advisory Group is being established to ground the organization in Te Tiriti o Waitangi principles.

The business model is charitable rather than commercial: services are provided free of charge to patients and families, and revenue derives from donations (prominent donate button on the website), grants, fundraising events including the annual Rare Beer Challenge, and pharmaceutical industry engagement through the Round Table of Companies. RDNZ does not have investors or shareholders and is governed by a Board of Trustees chaired by Ariane Tuapola, with Chief Executive Chris Higgins also chairing the NZ ERDERA National Mirror Group. Revenue, headcount, and audited financials are not publicly disclosed, consistent with a small national charity footprint.

Rare Disorders Nz firmographics

Firmographics
Name
Rare Disorders Nz
Legal name
Rare Disorders New Zealand
Website
https://raredisorders.org.nz
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
Rare Disorders New Zealand (RDNZ) is a Wellington-based registered charity and the collective voice for approximately 300,000 New Zealanders living with a rare disorder, representing over 150 disorder-specific support groups through advocacy, support services, parliamentary engagement, and a national rare disorders research network.
Ownership category
akta.pro rank

Rare Disorders Nz industry classification

Industry
Product category
Rare Disease Advocacy Services
NAICS
Individual and Family Services (6241), Other Similar Organizations (except Business, Professional, Labor, and Political Organizations) (813990), Human Rights Organizations (813311)
SIC
Services-Social Services (8300), Services-Membership Organizations (8600), Services-Health Services (8000)
akta.pro industry
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYBPAGACAH
Patient Advocacy, Navigation & Access to Care
SECONDARYHLAJAJAE
Disease Registries (Cancer, Immunization, Rare Disease, etc.)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics

Keywords

  • Rare disease advocacy
  • Patient support services
  • Disorder support groups
  • Health policy advocacy
  • Rare disorders research

Where Rare Disorders Nz is headquartered

Location

Headquarters

HQ city
Wellington
HQ country
New Zealand
HQ region
Oceania

Offices1 record

Markets served

Rare Disorders Nz business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Donations and Charitable Funding: Rare Disorders NZ operates as a registered charity and relies on donations from the public (evidenced by prominent donate buttons on their website), grants, and potentially government funding to support their advocacy and support services for the rare disorders community.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Rare Disorders Nz product offering

Product offering

Core offering

Rare Disorders NZ is a registered charity that serves as the collective voice for the approximately 300,000 New Zealanders living with a rare disorder. The organization coordinates a network of 150+ disorder-specific support groups, delivers patient and caregiver resources, advocates for policy change through parliamentary channels, and operates the national Rare Disorders Research Network connecting researchers across institutions.

Product overview

Rare Disorders NZ is a national advocacy charity, not a product company. The organization serves as the collective voice for approximately 300,000 New Zealanders living with rare disorders. Its offerings consist of support services (support group directory, patient resources, mental health support, self-advocacy resources), advocacy initiatives (the Cross-Party MP Group, Māori Advisory Group, Rare Disorders Strategy), research infrastructure (Rare Disorders Research Network connecting over 50 researchers), financial support guidance (disability funding, Work and Income resources, other financial support), and information resources (genetic testing information, transition to independent living guides, parent and caregiver guide). These services work together to improve healthcare and wellbeing for people with rare health conditions through support, advocacy, and research coordination.

Differentiator

Problem solved

Functional benefit

Products and services

  • Support Group Directory A searchable directory of over 150 disorder-specific support groups connecting patients and families with rare disorders in New Zealand.
  • Rare Disorders Research Network (RDRN)

Quantifiable outcome

  • First-ever Rare Disorders Strategy for New Zealand achieved through advocacy efforts
  • +2 more outcomes

Companies that use Rare Disorders Nz

Customer profile

Segments4 records

Ideal customer profiles3 records

Rare Disorders Nz technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Rare Disorders Nz partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core, flagship and major.

  • Victoria University of Wellington (School of Nursing, Midwifery and Health Practice)coreStrategic or Co-development Partner · 1 December 2024Joint collaboration establishing New Zealand's Rare Disorders Research Network. Professor Karen McBride-Henry and Dr Tara Officer received HRC Health Delivery Research Activation Grant for rare disorders research. The network is co-chaired by RDNZ Chief Executive Chris Higgins and Associate Professor Phillip Wilcox (University of Otago).
  • University of OtagocoreStrategic or Co-development PartnerLeads rare disorders research through Associate Professor Phillip Wilcox (Māori Variome project, He Kākano) and Professor Louise Bicknell (ERDERA ambassador). Multiple research leadership group members from University of Otago including Stephanie Hughes (RARITY initiative) and Louise Bicknell.
  • European Rare Diseases Research Alliance (ERDERA)flagshipStrategic or Co-development PartnerNZ became the 19th National Mirror Group and first Southern Hemisphere non-European country recognized by ERDERA in late 2025. ERDERA has 185 organisations across 37 countries with €385 million budget. NZ NMG connects New Zealand researchers with international rare disease networks and provides potential gateway to Horizon Europe research programme.
  • University of Auckland (Liggins Institute)coreStrategic or Co-development PartnerProfessor Justin O'Sullivan leads work on fast-tracking rare disease from diagnosis to custom therapies. Research on acute care genetics, trio sequencing, newborn genetic testing projects. Partnership with Māori Research Advisory Group.
  • Round Table of Companies (Pharmaceutical Companies)coreGTM or Marketing PartnerEstablished 2019. Forum of pharmaceutical companies with interest in orphan drugs and therapeutic interventions for rare disorders in New Zealand. Holds two meetings annually. Provides transparent working relationships between industry and patient community while maintaining RDNZ independence. Current members include multiple pharmaceutical company logos (specific companies not named in text).
  • Australian National Mirror Group (via Perth Children's Hospital Rare Care Centre)majorStrategic or Co-development PartnerCollaboration through Catalyst-funded NMG/Australian partnership project. Professor Gareth Baynam leads Australian efforts. Cross-sector rare disorders research framework sharing. Plans for joint meetings and knowledge sharing on rare disease models of care.
  • Cross-Party Parliamentary Group on Rare and Undiagnosed Disorders (CPGRD)flagshipOthersFormally established 12 March 2025 with support from Associate Minister of Health Hon. David Seymour. 14 MPs from multiple parties. National MP Hamish Campbell as Chair, Labour MP Hon. Dr. Ayesha Verrall as Deputy Chair. RDNZ provides secretariat support. Quarterly meetings.

Scale indicators5 records

Recent moves5 records

Expansion highlights6 records

Rare Disorders Nz competitors and assessment

Company assessment

Direct peers

  • EURORDIS - Rare Diseases Europe: European umbrella for rare disease patient organisations; directly comparable as a federation of national rare disease alliances driving cross-border policy, research, and advocacy—mirroring RDNZ's role at a smaller scale within NZ and recently joining ERDERA.
  • Genetic Alliance UK: UK umbrella for genetic and rare condition support groups; directly comparable structure—membership-based federation of condition-specific groups providing advocacy, information, and policy influence.
  • Canadian Organization for Rare Disorders (CORD): Canada's national rare disease patient alliance; comparable as a national umbrella advocating for a national rare disease strategy, drug access reform, and research funding, with member support groups analogous to RDNZ's collective.
  • Rare Voices Australia: Australia's national rare disease advocacy body; operates the same collective-voice model serving patients across disease areas, drives national rare disease policy, and partners with RDNZ via the joint Catalyst-funded NMG initiative.

Broad incumbents

  • National Organization for Rare Disorders (NORD): Largest US rare disease advocacy organisation; directly comparable as a national collective voice for rare disease patients and a major policy/advocacy umbrella, with a much larger scale and portfolio including research grants and patient registries.

Others

  • Orphanet: Global reference portal for rare diseases and orphan drugs providing disease classification, prevalence data, and expert resources; adjacent infrastructure that RDNZ draws upon for its 7,000-disorder framing and research evidence base.

Regional players

  • Rare Disease UK: UK campaign focused on rare disease policy and strategy development; comparable mission in driving national rare disease frameworks, similar to RDNZ's advocacy for NZ's first Rare Disorders Strategy.
  • Malaysian Rare Disorders Society: Malaysia-based rare disease patient advocacy group operating across a similarly small national population; shares the Asia-Pacific context, emerging-policy landscape, and community-collective advocacy model.

Market position

Strengths4 records

Weaknesses3 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Rare Disorders Nz social profiles

Digital presence

Rare Disorders Nz financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rare Disorders Nz leadership team

Management profile

Number of profiles

Profiles2 records

Rare Disorders Nz funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rare Disorders Nz M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rare Disorders Nz

What does Rare Disorders Nz do?

Rare Disorders NZ is a registered charity that serves as the collective voice for the approximately 300,000 New Zealanders living with a rare disorder. The organization coordinates a network of 150+ disorder-specific support groups, delivers patient and caregiver resources, advocates for policy change through parliamentary channels, and operates the national Rare Disorders Research Network connecting researchers across institutions.

Is Rare Disorders Nz a public or private company?

Rare Disorders Nz is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Rare Disorders Nz founded?

Rare Disorders Nz was founded in 2017. It employs 1 to 10 people.

Where is Rare Disorders Nz based?

Rare Disorders Nz is headquartered in Wellington, New Zealand, in the Oceania region.

How does Rare Disorders Nz make money?

One revenue line is on record: donations and Charitable Funding.

Who are Rare Disorders Nz's main competitors?

Direct peers on record are EURORDIS - Rare Diseases Europe, Genetic Alliance UK, Canadian Organization for Rare Disorders (CORD) and Rare Voices Australia. National Organization for Rare Disorders (NORD) is listed as a broad incumbent. Orphanet is listed as an others. Regional players are Rare Disease UK and Malaysian Rare Disorders Society.

Does Rare Disorders Nz have an API?

No public API is recorded for Rare Disorders Nz.

What industry is Rare Disorders Nz in?

Rare Disorders Nz's product category is Rare Disease Advocacy Services. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations, with a secondary code of BPAGACAH, Patient Advocacy, Navigation & Access to Care. Its NAICS code is 6241 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales